436093-17-3 Usage
Uses
Used in Pharmaceutical Industry:
1-(cyclohexylcarbonyl)piperidine-4-carboxylic acid is used as a key intermediate in the synthesis of various bioactive molecules and potential pharmaceuticals. Its structural diversity and functional groups enable the development of compounds with diverse biological activities, making it a valuable asset in drug discovery and design.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(cyclohexylcarbonyl)piperidine-4-carboxylic acid serves as a versatile building block for the creation of complex molecular structures. Its cyclohexylcarbonyl and carboxylic acid groups can be further modified or used as starting points for the synthesis of a wide range of organic compounds with potential applications in various industries.
Used in Medicinal Chemistry:
1-(cyclohexylcarbonyl)piperidine-4-carboxylic acid is used as a starting material or a structural component in the design and synthesis of novel drug candidates. Its unique properties and reactivity allow for the development of pharmaceuticals with improved efficacy, selectivity, and safety profiles, contributing to the advancement of medical treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 436093-17-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,6,0,9 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 436093-17:
(8*4)+(7*3)+(6*6)+(5*0)+(4*9)+(3*3)+(2*1)+(1*7)=143
143 % 10 = 3
So 436093-17-3 is a valid CAS Registry Number.
436093-17-3Relevant articles and documents
CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF
-
Paragraph 0326; 0328, (2019/04/05)
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.